Correlation Between Sharps Technology and Microbot Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sharps Technology and Microbot Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sharps Technology and Microbot Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sharps Technology and Microbot Medical, you can compare the effects of market volatilities on Sharps Technology and Microbot Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sharps Technology with a short position of Microbot Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sharps Technology and Microbot Medical.

Diversification Opportunities for Sharps Technology and Microbot Medical

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sharps and Microbot is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Sharps Technology and Microbot Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbot Medical and Sharps Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sharps Technology are associated (or correlated) with Microbot Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbot Medical has no effect on the direction of Sharps Technology i.e., Sharps Technology and Microbot Medical go up and down completely randomly.

Pair Corralation between Sharps Technology and Microbot Medical

Given the investment horizon of 90 days Sharps Technology is expected to under-perform the Microbot Medical. But the stock apears to be less risky and, when comparing its historical volatility, Sharps Technology is 1.08 times less risky than Microbot Medical. The stock trades about -0.05 of its potential returns per unit of risk. The Microbot Medical is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  328.00  in Microbot Medical on November 2, 2024 and sell it today you would lose (136.00) from holding Microbot Medical or give up 41.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sharps Technology  vs.  Microbot Medical

 Performance 
       Timeline  
Sharps Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sharps Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Microbot Medical 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sharps Technology and Microbot Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sharps Technology and Microbot Medical

The main advantage of trading using opposite Sharps Technology and Microbot Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sharps Technology position performs unexpectedly, Microbot Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will offset losses from the drop in Microbot Medical's long position.
The idea behind Sharps Technology and Microbot Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals